He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
In this video, Dr Krysko discusses the findings from her study on the real-world effectiveness of newer vs injectable disease-modifying therapies among pediatric patients with multiple sclerosis.
In his last video, Garret Duron, MD, explained which questions rheumatologists can ask themselves when determining whether a piece of COVID-19 literature will be helpful to them. But what information would...
In this 4-minute video, Raymond Cross, MD, from the University of Maryland, reviews his discussion of managing patients with mild to moderate ulcerative colitis, which he presented at the virtual Advances...
